Harnessing gene power to make
treatment accessible to all
About AnGes
News
All
Development
Product Info
IR
Information
- 2026.05.14Development
- Notice Regarding the Conduct of a Type B CMC Meeting for the HGF gene therapy product
- 2026.05.08IR
- Financial Results Summary of 1st Quarter 2026
- 2026.04.30Development
- COLLATEGENE® (HGF gene therapy product); Proprietary ＆ USAN Names